These findings, of course, do not exclude a role of the ASM-ceramide system in the tumor microenvironment, i.e. the non-malignant cells in the glioma microenvironment in vivo, for sensitizing to irradiation and/or alkylating agents. This evidence concerns the gene SMPD1 and central nervous system cancer.